Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.68%

Published 11/25/2019, 05:25 PM
Updated 11/25/2019, 05:25 PM
© Reuters.  U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.68%

Investing.com – U.S. stocks were higher after the close on Monday, as gains in the Technology, Healthcare and Industrials sectors led shares higher.

At the close in NYSE, the Dow Jones Industrial Average gained 0.68% to hit a new all time high, while the S&P 500 index added 0.75%, and the NASDAQ Composite index gained 1.32%.

The best performers of the session on the Dow Jones Industrial Average were UnitedHealth Group Incorporated (NYSE:UNH), which rose 2.11% or 5.83 points to trade at 282.67 at the close. Meanwhile, Intel Corporation (NASDAQ:INTC) added 2.08% or 1.20 points to end at 58.81 and Dow Inc (NYSE:DOW) was up 1.86% or 1.01 points to 55.20 in late trade.

The worst performers of the session were Exxon Mobil Corp (NYSE:XOM), which fell 0.66% or 0.46 points to trade at 68.91 at the close. McDonald’s Corporation (NYSE:MCD) declined 0.65% or 1.25 points to end at 191.89 and Verizon Communications Inc (NYSE:VZ) was down 0.62% or 0.37 points to 59.38.

The top performers on the S&P 500 were L Brands Inc (NYSE:LB) which rose 6.44% to 19.17, Tiffany & Co (NYSE:TIF) which was up 6.17% to settle at 133.25 and Incyte Corporation (NASDAQ:INCY) which gained 5.94% to close at 94.00.

The worst performers were Comcast Corp (NASDAQ:CMCSA) which was down 3.24% to 43.35 in late trade, Jacobs Engineering Group Inc (NYSE:JEC) which lost 2.82% to settle at 90.75 and JM Smucker Company (NYSE:SJM) which was down 2.37% to 105.83 at the close.

The top performers on the NASDAQ Composite were Sorrento Therape (NASDAQ:SRNE) which rose 94.38% to 3.11, Janone Inc (NASDAQ:JAN) which was up 54.51% to settle at 3.9400 and Diffusion Pharmaceuticals Inc (NASDAQ:DFFN) which gained 51.61% to close at 0.4700.

The worst performers were Cymabay Therapeu (NASDAQ:CBAY) which was down 75.86% to 1.340 in late trade, La Jolla Pharmaceutical Co (NASDAQ:LJPC) which lost 53.58% to settle at 2.59 and Adamis Pharma (NASDAQ:ADMP) which was down 50.96% to 0.62 at the close.

Rising stocks outnumbered declining ones on the New York Stock Exchange by 2057 to 783 and 91 ended unchanged; on the Nasdaq Stock Exchange, 2034 rose and 626 declined, while 68 ended unchanged.

Shares in Tiffany & Co (NYSE:TIF) rose to 52-week highs; up 6.17% or 7.74 to 133.25. Shares in Incyte Corporation (NASDAQ:INCY) rose to 52-week highs; up 5.94% or 5.27 to 94.00. Shares in Cymabay Therapeu (NASDAQ:CBAY) fell to 3-years lows; losing 75.86% or 4.210 to 1.340. Shares in La Jolla Pharmaceutical Co (NASDAQ:LJPC) fell to 5-year lows; losing 53.58% or 2.99 to 2.59.

The CBOE Volatility Index, which measures the implied volatility of S&P 500 options, was down 3.81% to 11.87 a new 52-week low.

Gold Futures for February delivery was down 0.58% or 8.55 to $1461.95 a troy ounce. Elsewhere in commodities trading, Crude oil for delivery in January rose 0.24% or 0.14 to hit $57.91 a barrel, while the February Brent oil contract unchanged 0.00% or 0.00 to trade at $62.53 a barrel.

EUR/USD was down 0.01% to 1.1012, while USD/JPY rose 0.03% to 108.94.

The US Dollar Index Futures was up 0.04% at 98.218.

Latest comments

Now this news seems to good at least it's not about trade war. This is what I expect
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.